FOXK2 and bladder transitional cell carcinoma: Specifically, FOXK2 was found to be significantly overexpressed in tumor tissues of prostate adenocarcinoma (PRAD), endometrial cancer (UCEC), BLCA, CRC, pancreatic duct adenocarcinoma (PDAC), STAD, lung cancer, and thyroid cancer.